カテゴリー： Transparency Market Research, 世界, 医療/バイオ

C反応性タンパク質検査の世界市場2023～2031：検査別、分析別

◆英語タイトル：C-reactive Protein Testing Market (Test Type: Standard C-reactive Protein Test and High-sensitivity C-reactive Protein; Type of Assay: ELISA, Immunoturbidimetry, Immuno-chromatography, Immunofluorescence, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが発行した調査報告書（TMR23JUL058）◆商品コード：TMR23JUL058
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年4月
◆ページ数：194
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ
◆産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の当調査レポートでは、世界のC反応性タンパク質検査市場規模が、2023年の31億ドルから2031年までに40億ドルに拡大し、予測期間中に年平均（CAGR）2.9%で成長すると推測しています。本書は、C反応性タンパク質検査の世界市場について詳しく調査し、市場状況及び展望についてまとめています。序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、検査別（一般C反応性タンパク質検査、高感度C反応性タンパク質）分析、分析別（ELISA、免疫比濁法、免疫クロマトグラフィー法、免疫蛍光法、その他）分析、疾患別（心臓疾患、炎症性疾患、感染症、その他）分析、エンドユーザー別（病院関連研究所、独立診断研究所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成で掲載しています。また、市場参入企業として、Agilent Technologies, Inc.、Laboratory Corporation of America Holdings、Thermo Fisher Scientific、Abbott Laboratories、F. Hoffmann-La Roche Ltd.、Creative Diagnostics、DxGen Corp.、CTK Biotech, Inc.、Getein Biotech, Inc.、Goldsite Diagnostics, Inc.、OptiBio Co., Ltd.、Nanjing Vazyme Biotech Co., Ltd.などを含んでいます。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要インサイト
・世界のC反応性タンパク質検査市場規模：検査別
- 一般C反応性タンパク質検査の市場規模
- 高感度C反応性タンパク質の市場規模
・世界のC反応性タンパク質検査市場規模：分析別
- ELISAにおける市場規模
- 免疫比濁法における市場規模
- 免疫クロマトグラフィー法における市場規模
- 免疫蛍光法における市場規模
- その他分析における市場規模
・世界のC反応性タンパク質検査市場規模：疾患別
- 心臓疾患における市場規模
- 炎症性疾患における市場規模
- 感染症における市場規模
- その他疾患における市場規模
・世界のC反応性タンパク質検査市場規模：エンドユーザー別
- 病院関連研究所における市場規模
- 独立診断研究所における市場規模
- その他エンドユーザーにおける市場規模
・世界のC反応性タンパク質検査市場規模：地域別
- 北米のC反応性タンパク質検査市場規模
- ヨーロッパのC反応性タンパク質検査市場規模
- アジア太平洋のC反応性タンパク質検査市場規模
- 中南米のC反応性タンパク質検査市場規模
- 中東・アフリカのC反応性タンパク質検査市場規模
・競争状況

C-Reactive Protein Testing Market – Scope of Report
TMR’s report on the global C-Reactive Protein Testing Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global C-Reactive Protein Testing Market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global C-Reactive Protein Testing Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Plasmonic Materials market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Plasmonic Materials market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Plasmonic Materials market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Plasmonic Materials market.

The report delves into the competitive landscape of the global Plasmonic Materials market. Key players operating in the global C-Reactive Protein Testing Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global C-Reactive Protein Testing Market profiled in this report.

Key Questions Answered in Global C-Reactive Protein Testing Market Report
• What is the sales/revenue generated by Plasmonic Materials across all regions during the forecast period?
• What are the opportunities in the global Plasmonic Materials market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

C-Reactive Protein Testing Market – Research Objectives and Research Approach
The comprehensive report on the global C-Reactive Protein Testing Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global C-Reactive Protein Testing Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Plasmonic Materials market.”

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global C-reactive Protein Testing Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global C-reactive Protein Testing Market Analysis and Forecast, 2017–2031
5. Key Insights
    5.1. Overview of C-reactive Protein Testing Market
    5.2. Key Product/ Brand Analysis
    5.3. Pipeline Analysis
    5.4. COVID-19 Pandemic Impact on Industry
6. Global C-reactive Protein Testing Market Analysis and Forecast, by Test Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Test Type, 2017–2031
        6.3.1. Standard C-reactive Protein Test
        6.3.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    6.4. Market Attractiveness Analysis, by Test Type
7. Global C-reactive Protein Testing Market Analysis and Forecast, by Type of Assay
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Type of Assay, 2017–2031
        7.3.1. ELISA
        7.3.2. Immunoturbidimetry
        7.3.3. Immuno-chromatography
        7.3.4. Immunofluorescence
        7.3.5. Others
    7.4. Market Attractiveness Analysis, by Type of Assay
8. Global C-reactive Protein Testing Market Analysis and Forecasts, by Indication
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Indication, 2017–2031
        8.3.1. Heart Diseases
        8.3.2. Inflammatory Diseases
        8.3.3. Infectious Diseases
        8.3.4. Others
    8.4. Market Attractiveness Analysis, by Indication
9. Global C-reactive Protein Testing Market Analysis and Forecast, by End-user
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by End-user, 2017–2031
        9.3.1. Hospital Associated Laboratories
        9.3.2. Independent Diagnostic Laboratories
        9.3.3. Others
    9.4. Market Attractiveness Analysis, by End-user
10. Global C-reactive Protein Testing Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region, 2017–2031
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness Analysis, by Region
11. North America C-reactive Protein Testing Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Test Type, 2017–2031
        11.2.1. Standard C-reactive Protein Test
        11.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    11.3. Market Value Forecast, by Type of Assay, 2017–2031
        11.3.1. ELISA
        11.3.2. Immunoturbidimetry
        11.3.3. Immuno-chromatography
        11.3.4. Immunofluorescence
        11.3.5. Others
    11.4. Market Value Forecast, by Indication, 2017–2031
        11.4.1. Heart Diseases
        11.4.2. Inflammatory Diseases
        11.4.3. Infectious Diseases
        11.4.4. Others
    11.5. Market Value Forecast, by End-user, 2017–2031
        11.5.1. Hospital Associated Laboratories
        11.5.2. Independent Diagnostic Laboratories
        11.5.3. Others
    11.6. Market Value Forecast, by Country, 2017–2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Test Type
        11.7.2. By Type of Assay
        11.7.3. By Indication
        11.7.4. By End-user
        11.7.5. By Country
12. Europe C-reactive Protein Testing Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Test Type, 2017–2031
        12.2.1. Standard C-reactive Protein Test
        12.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    12.3. Market Value Forecast, by Type of Assay, 2017–2031
        12.3.1. ELISA
        12.3.2. Immunoturbidimetry
        12.3.3. Immuno-chromatography
        12.3.4. Immunofluorescence
        12.3.5. Others
    12.4. Market Value Forecast, by Indication, 2017–2031
        12.4.1. Heart Diseases
        12.4.2. Inflammatory Diseases
        12.4.3. Infectious Diseases
        12.4.4. Others
    12.5. Market Value Forecast, by End-user, 2017–2031
        12.5.1. Hospital Associated Laboratories
        12.5.2. Independent Diagnostic Laboratories
        12.5.3. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Italy
        12.6.5. Spain
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Test Type
        12.7.2. By Type of Assay
        12.7.3. By Indication
        12.7.4. By End-user
        12.7.5. By Country/Sub-region
13. Asia Pacific C-reactive Protein Testing Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Test Type, 2017–2031
        13.2.1. Standard C-reactive Protein Test
        13.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    13.3. Market Value Forecast, by Type of Assay, 2017–2031
        13.3.1. ELISA
        13.3.2. Immunoturbidimetry
        13.3.3. Immuno-chromatography
        13.3.4. Immunofluorescence
        13.3.5. Others
    13.4. Market Value Forecast, by Indication, 2017–2031
        13.4.1. Heart Diseases
        13.4.2. Inflammatory Diseases
        13.4.3. Infectious Diseases
        13.4.4. Others
    13.5. Market Value Forecast, by End-user, 2017–2031
        13.5.1. Hospital Associated Laboratories
        13.5.2. Independent Diagnostic Laboratories
        13.5.3. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Test Type
        13.7.2. By Type of Assay
        13.7.3. By Indication
        13.7.4. By End-user
        13.7.5. By Country/Sub-region
14. Latin America C-reactive Protein Testing Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Test Type, 2017–2031
        14.2.1. Standard C-reactive Protein Test
        14.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    14.3. Market Value Forecast, by Type of Assay, 2017–2031
        14.3.1. ELISA
        14.3.2. Immunoturbidimetry
        14.3.3. Immuno-chromatography
        14.3.4. Immunofluorescence
        14.3.5. Others
    14.4. Market Value Forecast, by Indication, 2017–2031
        14.4.1. Heart Diseases
        14.4.2. Inflammatory Diseases
        14.4.3. Infectious Diseases
        14.4.4. Others
    14.5. Market Value Forecast, by End-user, 2017–2031
        14.5.1. Hospital Associated Laboratories
        14.5.2. Independent Diagnostic Laboratories
        14.5.3. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Test Type
        14.7.2. By Type of Assay
        14.7.3. By Indication
        14.7.4. By End-user
        14.7.5. By Country/Sub-region
15. Middle East & Africa C-reactive Protein Testing Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Test Type, 2017–2031
        15.2.1. Standard C-reactive Protein Test
        15.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
    15.3. Market Value Forecast, by Type of Assay, 2017–2031
        15.3.1. ELISA
        15.3.2. Immunoturbidimetry
        15.3.3. Immuno-chromatography
        15.3.4. Immunofluorescence
        15.3.5. Others
    15.4. Market Value Forecast, by Indication, 2017–2031
        15.4.1. Heart Diseases
        15.4.2. Inflammatory Diseases
        15.4.3. Infectious Diseases
        15.4.4. Others
    15.5. Market Value Forecast, by End-user, 2017–2031
        15.5.1. Hospital Associated Laboratories
        15.5.2. Independent Diagnostic Laboratories
        15.5.3. Others
    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Test Type
        15.7.2. By Type of Assay
        15.7.3. By Indication
        15.7.4. By End-user
        15.7.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player – Competition Matrix (by tier and size of companies)
    16.2. Market Share Analysis, by Company (2022)
    16.3. Company Profiles
        16.3.1. Agilent Technologies, Inc.
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Laboratory Corporation of America Holdings
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. Thermo Fisher Scientific
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Abbott Laboratories
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. F. Hoffmann-La Roche Ltd.
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Creative Diagnostics
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. DxGen Corp
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. CTK Biotech, Inc.
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Getein Biotech, Inc.
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. Goldsite Diagnostics, Inc.
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. OptiBio Co., Ltd.
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Product Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview
        16.3.12. Nanjing Vazyme Biotech Co., Ltd.
            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.12.2. Product Portfolio
            16.3.12.3. Financial Overview
            16.3.12.4. SWOT Analysis
            16.3.12.5. Strategic Overview

List of Tables

Table 01: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 02: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031

Table 03: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 04: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 05: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 06: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 08: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031

Table 09: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 10: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 11: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 13: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031

Table 14: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 15: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 18: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031

Table 19: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 20: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 23: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031

Table 24: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 25: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 26: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 27: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 28: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031

Table 29: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 30: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ C反応性タンパク質検査の世界市場2023～2031：検査別、分析別(C-reactive Protein Testing Market (Test Type: Standard C-reactive Protein Test and High-sensitivity C-reactive Protein; Type of Assay: ELISA, Immunoturbidimetry, Immuno-chromatography, Immunofluorescence, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • エクソソーム技術の世界市場2023～2031：エクソソーム種類別
  • 遺伝子検査サービスの世界市場2023～2031：検査種類別
  • ウイルスベクター製造の世界市場2023～2031：ベクター種類別

    • ◆H&Iグローバルリサーチのお客様（例）◆